Cerebrospinal fluid concentrations of corticotropin-releasing hormone (CRH) and diazepam-binding inhibitor (DBI) during alcohol withdrawal and abstinence

Bryon Adinoff, Ray Anton, Markku Linnoila, Alessandra Guidotti, Charles B. Nemeroff, Garth Bissette

Research output: Contribution to journalArticle

59 Citations (Scopus)

Abstract

The neuropeptides diazepam binding inhibitor (DBI) and corticotropin-releasing hormone (CRH) elicit anxiety-like symptoms when administered intracerebroventricularly to laboratory animals. Because of the similarities between the symptoms of certain anxiety states and the alcohol withdrawal syndrome, we hypothesized that increased secretion of either of these endogenous neuropeptides may at least in part, be responsible for the symptoms of alcohol withdrawal. We therefore measured DBI and CRH concentrations in cerebrospinal fluid (CSF) of 15 alcohol-dependent patients during acute withdrawal (Day 1) and again at 3 week's abstinence (Day 21). In addition, plasma concentrations of cortisol were measured to evaluate the relationship between pituitary-adrenal axis activation and CSF CRH concentrations. CSF CRH (p < .04), but not CSF DBI, was significantly higher on Day 1 than on Day 21. Although there was a significant decrease in plasma cortisol from Day 1 to Day 21 (p < .001), a significant correlation between CSF CRH and plasma cortisol concentrations was not observed at either time point. Neither CSF neutropeptide correlated with clinical measures of withdrawal severity. These tentative findings may implicate CRH, but not DBI, in the pathogenesis of alcohol withdrawal. Alternately, the central release of CRH and DBI may not be adequately reflected in lumbar CSF.

Original languageEnglish (US)
Pages (from-to)288-295
Number of pages8
JournalNeuropsychopharmacology
Volume15
Issue number3
DOIs
StatePublished - Sep 1996

Fingerprint

Diazepam Binding Inhibitor
Alcohol Abstinence
Corticotropin-Releasing Hormone
Cerebrospinal Fluid
Alcohols
Hydrocortisone
Neuropeptides
Anxiety
Substance Withdrawal Syndrome
Laboratory Animals

Keywords

  • Alcohol withdrawal
  • Alcoholism
  • Corticotropin releasing hormone
  • Diazepam binding inhibitor
  • GABA receptor
  • HPA axis

ASJC Scopus subject areas

  • Pharmacology

Cite this

Cerebrospinal fluid concentrations of corticotropin-releasing hormone (CRH) and diazepam-binding inhibitor (DBI) during alcohol withdrawal and abstinence. / Adinoff, Bryon; Anton, Ray; Linnoila, Markku; Guidotti, Alessandra; Nemeroff, Charles B.; Bissette, Garth.

In: Neuropsychopharmacology, Vol. 15, No. 3, 09.1996, p. 288-295.

Research output: Contribution to journalArticle

Adinoff, Bryon ; Anton, Ray ; Linnoila, Markku ; Guidotti, Alessandra ; Nemeroff, Charles B. ; Bissette, Garth. / Cerebrospinal fluid concentrations of corticotropin-releasing hormone (CRH) and diazepam-binding inhibitor (DBI) during alcohol withdrawal and abstinence. In: Neuropsychopharmacology. 1996 ; Vol. 15, No. 3. pp. 288-295.
@article{382063692992441e9f31540ad45164fc,
title = "Cerebrospinal fluid concentrations of corticotropin-releasing hormone (CRH) and diazepam-binding inhibitor (DBI) during alcohol withdrawal and abstinence",
abstract = "The neuropeptides diazepam binding inhibitor (DBI) and corticotropin-releasing hormone (CRH) elicit anxiety-like symptoms when administered intracerebroventricularly to laboratory animals. Because of the similarities between the symptoms of certain anxiety states and the alcohol withdrawal syndrome, we hypothesized that increased secretion of either of these endogenous neuropeptides may at least in part, be responsible for the symptoms of alcohol withdrawal. We therefore measured DBI and CRH concentrations in cerebrospinal fluid (CSF) of 15 alcohol-dependent patients during acute withdrawal (Day 1) and again at 3 week's abstinence (Day 21). In addition, plasma concentrations of cortisol were measured to evaluate the relationship between pituitary-adrenal axis activation and CSF CRH concentrations. CSF CRH (p < .04), but not CSF DBI, was significantly higher on Day 1 than on Day 21. Although there was a significant decrease in plasma cortisol from Day 1 to Day 21 (p < .001), a significant correlation between CSF CRH and plasma cortisol concentrations was not observed at either time point. Neither CSF neutropeptide correlated with clinical measures of withdrawal severity. These tentative findings may implicate CRH, but not DBI, in the pathogenesis of alcohol withdrawal. Alternately, the central release of CRH and DBI may not be adequately reflected in lumbar CSF.",
keywords = "Alcohol withdrawal, Alcoholism, Corticotropin releasing hormone, Diazepam binding inhibitor, GABA receptor, HPA axis",
author = "Bryon Adinoff and Ray Anton and Markku Linnoila and Alessandra Guidotti and Nemeroff, {Charles B.} and Garth Bissette",
year = "1996",
month = "9",
doi = "10.1016/0893-133X(95)00212-V",
language = "English (US)",
volume = "15",
pages = "288--295",
journal = "Neuropsychopharmacology",
issn = "0893-133X",
publisher = "Nature Publishing Group",
number = "3",

}

TY - JOUR

T1 - Cerebrospinal fluid concentrations of corticotropin-releasing hormone (CRH) and diazepam-binding inhibitor (DBI) during alcohol withdrawal and abstinence

AU - Adinoff, Bryon

AU - Anton, Ray

AU - Linnoila, Markku

AU - Guidotti, Alessandra

AU - Nemeroff, Charles B.

AU - Bissette, Garth

PY - 1996/9

Y1 - 1996/9

N2 - The neuropeptides diazepam binding inhibitor (DBI) and corticotropin-releasing hormone (CRH) elicit anxiety-like symptoms when administered intracerebroventricularly to laboratory animals. Because of the similarities between the symptoms of certain anxiety states and the alcohol withdrawal syndrome, we hypothesized that increased secretion of either of these endogenous neuropeptides may at least in part, be responsible for the symptoms of alcohol withdrawal. We therefore measured DBI and CRH concentrations in cerebrospinal fluid (CSF) of 15 alcohol-dependent patients during acute withdrawal (Day 1) and again at 3 week's abstinence (Day 21). In addition, plasma concentrations of cortisol were measured to evaluate the relationship between pituitary-adrenal axis activation and CSF CRH concentrations. CSF CRH (p < .04), but not CSF DBI, was significantly higher on Day 1 than on Day 21. Although there was a significant decrease in plasma cortisol from Day 1 to Day 21 (p < .001), a significant correlation between CSF CRH and plasma cortisol concentrations was not observed at either time point. Neither CSF neutropeptide correlated with clinical measures of withdrawal severity. These tentative findings may implicate CRH, but not DBI, in the pathogenesis of alcohol withdrawal. Alternately, the central release of CRH and DBI may not be adequately reflected in lumbar CSF.

AB - The neuropeptides diazepam binding inhibitor (DBI) and corticotropin-releasing hormone (CRH) elicit anxiety-like symptoms when administered intracerebroventricularly to laboratory animals. Because of the similarities between the symptoms of certain anxiety states and the alcohol withdrawal syndrome, we hypothesized that increased secretion of either of these endogenous neuropeptides may at least in part, be responsible for the symptoms of alcohol withdrawal. We therefore measured DBI and CRH concentrations in cerebrospinal fluid (CSF) of 15 alcohol-dependent patients during acute withdrawal (Day 1) and again at 3 week's abstinence (Day 21). In addition, plasma concentrations of cortisol were measured to evaluate the relationship between pituitary-adrenal axis activation and CSF CRH concentrations. CSF CRH (p < .04), but not CSF DBI, was significantly higher on Day 1 than on Day 21. Although there was a significant decrease in plasma cortisol from Day 1 to Day 21 (p < .001), a significant correlation between CSF CRH and plasma cortisol concentrations was not observed at either time point. Neither CSF neutropeptide correlated with clinical measures of withdrawal severity. These tentative findings may implicate CRH, but not DBI, in the pathogenesis of alcohol withdrawal. Alternately, the central release of CRH and DBI may not be adequately reflected in lumbar CSF.

KW - Alcohol withdrawal

KW - Alcoholism

KW - Corticotropin releasing hormone

KW - Diazepam binding inhibitor

KW - GABA receptor

KW - HPA axis

UR - http://www.scopus.com/inward/record.url?scp=0030249351&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030249351&partnerID=8YFLogxK

U2 - 10.1016/0893-133X(95)00212-V

DO - 10.1016/0893-133X(95)00212-V

M3 - Article

C2 - 8873112

AN - SCOPUS:0030249351

VL - 15

SP - 288

EP - 295

JO - Neuropsychopharmacology

JF - Neuropsychopharmacology

SN - 0893-133X

IS - 3

ER -